Lab suppliers working to sell lab equipment and increase life science sales leads at Utah life science marketing events may be interested in the latest grant news at the University of Utah. Researchers studying metabolic disorders such as obesity, diabetes and metabolic syndrome have received a $2.5 million award from the NIH. According to the NIH RePORTER, the study, titled “Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes,” will be led by University of Utah internal medicine researcher Andrew S. Weyrich, Ph.D. The project’s abstract states:
Read More
0 Comments Click here to read/write comments
Tags: 2014, 2013, Utah, university of utah, UUtah, Southwest, UT, BioResearch Product Faire Event, Salt Lake City, NIH funding, NIH grant
After receiving $2 million in philanthropic gifts in honor of Thomas Hartman, the Thomas Hartman Center for Parkinson’s Research in the Stony Brook University Department of Neurobiology and Behavior was dedicated in a ceremony on June 13th, 2013. Thomas Hartman was a much loved priest, television and radio personality, and believer in many causes who was diagnosed with Parkinson’s disease in 2004.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Northeast, New York, Stony Brook University, BioResearch Product Faire Event, Research Funding, NY, Stony Brook, funding news, SunySB
Science researchers at the University of Alabama at Birmingham recently received a $3 million grant that will be distributed over five years to join the Women’s Interagency HIV study (WIHS). Michael Saag, M.D. is the study’s principal investigator, and Mirjam-Collete Kempf, Ph.D., M.P.H. is the co-principal investigator. The researchers will begin recruiting women for the study this coming October.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Alabama, University of Alabama, Southern, BioResearch Product Faire Event, UAlab, Birmingham, AL, University of Alabama at Birmingham, new funding
Despite its effectiveness and potency, chemotherapy is highly disputed because at its base level, it’s exposing the body to high amounts of radiation. In some cases, the amount of radiation needed to kill a cancerous tumor is more than the human body can take. At the University of Michigan, Ann Arbor, researchers are working to change this by making humans more resistant to chemotherapy.
0 Comments Click here to read/write comments
Tags: University of Michigan, 2014, Midwest, 2013, Midwest life science marketing events, Ann Arbor, BioResearch Product Faire Event, MI, UMich
The Bill & Melinda Gates Foundation recently gave the University of North Carolina at Chapel Hill $8 million to improve the health of mothers and infants in Malawi. UNC Project-Malawi was originally established to address the HIV/AIDS crisis in Malawi, and now works in improving the problems associated with malaria, pediatrics, trauma, burns, cancer, family planning, emergency obstetrics, tuberculosis and other infectious diseases. This story comes in the wake of a report that North Carolina triangle universities received $2 billion in funding last school year.
1 Comment Click here to read/write comments
Tags: 2014, 2013, North Carolina, University of North Carolina, Southern, University of North Carolina Chapel Hill, BioResearch Product Faire Event, Front Line event, NC, Front Line, Chapel Hill, UNC
0 Comments Click here to read/write comments
Tags: 2014, 2013, Northeast, New York, Columbia University, Columbia, BioResearch Product Faire Event, NY, New York City
Science researchers at Georgetown University recently published a study in the Journal of Infectious Diseases that shows that the human papillomavirus (HPV) vaccine a Georgetown University doctor helped to invent has lead to the number of infections among teenage girls across the United States being cut in half. According to a Georgetown University news article, the vaccine was created to treat and get rid of two forms of the HPV virus, which results in most cervical cancer cases nationwide, along with head and neck cancer, anal cancer and penile cancer.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Georgetown University, Washington DC, Northeast, D.C., Geotwn, BioResearch Product Faire Event
Researchers at Ohio State University have come up with a dependable way to use a finger-stick blood sample to detect fibromyalgia syndrome, a complex pain disorder that often is complicated to diagnose. The test could potentially reduce the wait for diagnosis by five years if it’s someday made available to primary care physicians.
0 Comments Click here to read/write comments
Tags: 2014, Midwest, 2013, Ohio State University, Ohio, BioResearch Product Faire Event, Columbus, OH, OhStu, OSU
Depending on who you ask, antibiotics are the best and worst defense against disease-bearing bacteria. On the one hand, they are very effective and easy to administer. Unfortunately, the more we use them, the more bacteria learn to thrive in a so-called “antibacterial” environment, culminating in a worst-case scenario where all bacteria are entirely resistant to antibiotics. Fighting against that future are bioresearchers from the University of Illinois, Chicago, who are pursuing more clever ways to prevent microbes from diseasing us.
0 Comments Click here to read/write comments
Tags: 2014, Midwest, 2013, University of Illinois, University of Illinois Chicago, Illinois, BioResearch Product Faire Event, Chicago, IL, UI Chicago, UIChgo
Each year, Biotechnology Calendar, Inc. hosts over 55 BioResearch Product Faire™ events and 4 Biotechnology Vendor Showcase™ events all across the US. Of these shows, we have three BioResearch Product Faire™ Events in the state of Oregon: on the campuses of the University of Oregon, Oregon State University, and the Oregon Health and Science University.
0 Comments Click here to read/write comments
Tags: 2014, 2013, Oregon State University, Oregon Health and Science University, UOr, Northwest, University of Oregon, Oregon, BioResearch Product Faire Event, Life Sciences, Front Line event, Front Line, Corvallis, Eugene, OHSU, Portland, Bioresearch Equipment, ORSTU